Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Treasury Shares: 2016-2025

Historic Treasury Shares for Corcept Therapeutics (CORT) over the last 7 years, with Sep 2025 value amounting to $923.3 million.

  • Corcept Therapeutics' Treasury Shares rose 35.34% to $923.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $923.3 million, marking a year-over-year increase of 35.34%. This contributed to the annual value of $696.2 million for FY2024, which is 9.62% up from last year.
  • Per Corcept Therapeutics' latest filing, its Treasury Shares stood at $36.0 million for Q3 2025, which was up 2,329.15% from $1.5 million recorded in Q2 2025.
  • Corcept Therapeutics' Treasury Shares' 5-year high stood at $36.0 million during Q3 2025, with a 5-year trough of $20,000 in Q1 2024.
  • Moreover, its 3-year median value for Treasury Shares was $1.5 million (2025), whereas its average is $12.1 million.
  • Data for Corcept Therapeutics' Treasury Shares shows a peak YoY surged of 441.48% (in 2021) over the last 5 years.
  • Over the past 5 years, Corcept Therapeutics' Treasury Shares (Quarterly) stood at $410.4 million in 2021, then climbed by 11.14% to $456.1 million in 2022, then skyrocketed by 39.23% to $635.1 million in 2023, then climbed by 9.62% to $696.2 million in 2024, then skyrocketed by 35.34% to $923.3 million in 2025.
  • Its Treasury Shares was $923.3 million in Q3 2025, compared to $866.9 million in Q2 2025 and $744.7 million in Q1 2025.